Results 211 to 220 of about 330,080 (279)

Blood-brain barrier integrity during cardiopulmonary resuscitation in dogs. [PDF]

, 1990
Charles L. Schleien, Raymond C. Koehler, Donald H. Shaffner, Richard J. Traystman   +3 more
openalex   +1 more source

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Advanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar, Weiwei Guo, Xin Shen, Yimeng Fang, Yilin Liu, Peng‐Yuan Wang, Roey Elnathan, Yaping Chen   +7 more
wiley   +1 more source

Research developments in the neurovascular unit and the blood‑brain barrier (Review). [PDF]

Biomed Rep
Gong Y, Wu M, Huang Y, He X, Yuan J, Dang B.   +5 more
europepmc   +1 more source

Fine structural study of Mg-ATPase and alkaline phosphatase activities in the blood-brain barrier of ischemic rats.

, 1986
Shigehiko Ishiharajima, Shinsuke Fujita, Nobutaka Yamada, Gorô Asano   +3 more
openalex   +2 more sources

Genetic Engineering Methods in Primary T Cells

Advanced Therapeutics, EarlyView.
Primary T cells can be engineered to confer them with novel therapeutic functions, allowing them to treat a variety of conditions. Genetic engineering can be either stable or transient, aiming to either express or inhibit a target gene. This review discusses the various genetic engineering tools available as well as their characteristics and ...
Anthony Youssef, Hui‐Shan Li
wiley   +1 more source

Species-specific blood-brain barrier permeability in amphibians. [PDF]

BMC Biol
Antesberger S, Stiening B, Forsthofer M, Joven Araus A, Eroglu E, Huber J, Heß M, Straka H, Sanchez-Gonzalez R.   +8 more
europepmc   +1 more source

Changes in the permeability of fluorescein isothiocyanate dextrans to the blood-brain barrier by electroshock and carbon dioxide inhalation in mice

, 1986
Takeshi Koja, Chikara Kishita, Takao Shimizu, Kanji Izumi, Takeo Fukuda   +4 more
openalex   +1 more source

Evolution of Ocular Organ‐On‐Chip Systems for Disease Modelling and Drug Testing: Where are We Now?

Advanced Therapeutics, EarlyView.
The rise in ophthalmic diseases due to aging, screen use, and environmental factors has driven demand for better ocular models. Traditional systems fall short, encouraging the development of organ‐on‐chip devices. These microfluidic platforms replicate eye tissue architecture, enable drug screening, and simulate ocular diseases.
Sara Trujillo
wiley   +1 more source

The blood–brain barrier

Neurobiology of Disease, 2010
Alan M. Palmer
doaj  

Blood-brain barrier injury and neuroinflammation in pre-eclampsia and eclampsia. [PDF]

EBioMedicine
Bucher V, Herrock OT, Schell S, Visser J, Imberg H, Burke J, Zetterberg H, Blennow K, Walker SP, Tong S, Ek J, Cluver C, Bergman L.   +12 more
europepmc   +1 more source